Related Experiment Video
Updated: Jun 26, 2026

DNA Vector-based RNA Interference to Study Gene Function in Cancer
Published on: June 4, 2012
Applications of RNA interference in cancer therapeutics as a powerful tool for suppressing gene expression
Song He1, Dechun Zhang, Fang Cheng
1Molecular Medicine & Tumor Research Center, Chongqing Medical University, Chongqing, China. jarm190@163.com
Abstract:
Cancer poses a tremendous therapeutic challenge worldwide, highlighting the critical need for developing novel therapeutics. A promising cancer treatment modality is gene therapy, which is a form of molecular medicine designed to introduce into target cells genetic material with therapeutic intent. The history of RNA interference (RNAi) has only a dozen years, however, further studies have revealed that it is a potent method of gene silencing that has developed rapidly over the past few years as a result of its extensive importance in the study of genetics, molecular biology and physiology. RNAi is a natural process by which small interfering RNA (siRNA) duplex directs sequence specific post-transcriptional silencing of homologous genes by binding to its complementary mRNA and triggering its elimination. RNAi has been extensively used as a novel and effective gene silencing tool for the fundamental research of cancer therapeutics, and has displayed great potential in clinical treatment.
Insights
Gene therapy using RNA interference (RNAi) offers a potent method for gene silencing in cancer research. Small interfering RNA (siRNA) targets complementary mRNA, showing promise for novel cancer therapeutics and clinical treatment.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Cancer presents a significant global therapeutic challenge, necessitating the development of innovative treatments.
- Gene therapy, a form of molecular medicine, introduces genetic material into target cells for therapeutic purposes.
- RNA interference (RNAi) has emerged as a powerful gene silencing technique with broad applications in biological research.
Purpose of the Study:
- To explore the potential of RNA interference (RNAi) as a novel therapeutic strategy for cancer treatment.
- To highlight the mechanism of RNAi in gene silencing for fundamental cancer research.
- To assess the clinical applicability of RNAi-based cancer therapies.
Main Methods:
- Utilizing small interfering RNA (siRNA) duplexes to target and silence specific genes.
- Investigating the post-transcriptional gene silencing process mediated by RNA interference.
- Analyzing the efficacy of RNAi in preclinical cancer models and its potential for clinical translation.
Main Results:
- RNA interference effectively silences gene expression by degrading target messenger RNA (mRNA).
- siRNA-mediated gene silencing has demonstrated significant potential in fundamental cancer research.
- The application of RNAi in cancer therapeutics shows promising results for clinical treatment.
Conclusions:
- RNA interference is a potent and rapidly developing gene silencing tool with substantial importance in genetics and molecular biology.
- RNAi-based gene therapy represents a promising modality for addressing the therapeutic challenges posed by cancer.
- Further research and clinical application of RNAi hold great potential for advancing cancer treatment strategies.
More Related Videos
07:23Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
Published on: May 30, 2025
08:55RNA Interference in Aquatic Beetles as a Powerful Tool for Manipulating Gene Expression at Specific Developmental Time Points
Published on: May 29, 2020
Related Concept Videos
Experimental RNAi
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
MicroRNAs
MicroRNAs